Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Liz is Science Editor for Cancer Health, POZ, Hep and Real Health. She has been a health journalist and medical editor for more than 20 years, covering HIV, viral hepatitis, cancer and other health issues.
Judge’s ruling may pave the way for opening the nation’s first supervised overdose prevention facility.
Nine grants will enable researchers to study CBD and other components of marijuana.
Smoking cessation, a healthy diet, exercise and weight loss could dramatically reduce new liver cancer cases and liver disease deaths.
Experimental therapy led to weight loss and improved biomarkers of liver health.
Nonetheless, half of people with NAFLD were able to reach a 5% weight loss goal using a very low energy diet.
Well-tolerated insulin sensitizer may play a role in the treatment of fatty liver disease.
Sustained response to direct-acting antivirals prolonged survival by a year and a half.
HCV incidence in a Canadian study was lower than rates seen in some European countries.
People treated with Viread, Vemlidy or Baraclude are less likely to develop this malignancy.
Opdivo plus Yervoy led to higher response rates and longer survival than Opdivo alone.
Drugs that have a favorable effect on biomarkers may still play a role in combination therapy, however.
Some study participants experienced hepatitis B surface antigen loss, considered a functional cure.
A new study shows that people with the liver disease have substantial financial burden that can impact their care.
A new study confirms that providing clean drug injection equipment slows the spread of HIV.
Acting Commissioner Ned Sharpless will return to lead the National Cancer Institute.
Sci-B-Vac may offer more protection for older people and those with a weaker immune system.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.